PATHOPHYSIOLOGY OF AUTOIMMUNE DISORDERS

1. Introduction

Autoimmune disorders represent a group of complex and chronic diseases in which the body’s immune system mistakenly attacks its own cells, tissues, or organs. Normally, the immune system functions as a defense mechanism, distinguishing between self and non-self antigens to protect the body against pathogens. In autoimmunity, this self–non-self distinction breaks down, leading to self-directed immune responses that cause tissue damage and chronic inflammation.

More than 80 distinct autoimmune diseases have been identified, ranging from organ-specific conditions (e.g., Type 1 diabetes, Hashimoto’s thyroiditis) to systemic diseases (e.g., systemic lupus erythematosus, rheumatoid arthritis).
Understanding the pathophysiology—the underlying biological mechanisms of these disorders—is crucial for developing strategies for prevention, treatment, and holistic management.

2. Normal Immune Function

The immune system consists of innate and adaptive components that work together to defend the body.

• Innate Immunity: The first line of defense, involving physical barriers (skin, mucosa), phagocytic cells (macrophages, neutrophils), and natural killer (NK) cells.
• Adaptive Immunity: Provides specific responses through lymphocytes—T cells and B cells—and produces immunological memory.

Self-Tolerance

Under normal conditions, the immune system develops tolerance toward self-antigens through:

1. Central tolerance – destruction of self-reactive T and B cells during development (in thymus and bone marrow).
2. Peripheral tolerance – regulation by T regulatory (Treg) cells, anergy (cell inactivation), or deletion of self-reactive cells that escape into the periphery.

Failure of these mechanisms leads to autoimmunity.

3. Definition and Classification of Autoimmune Disorders

Autoimmune disorder:

A pathological condition arising from an abnormal immune response against self-antigens, resulting in tissue injury and functional impairment.

Classification

1. Organ-Specific Autoimmune Disorders: Affect single organs.
   • Examples: Type 1 diabetes (pancreas), Hashimoto’s thyroiditis (thyroid), Myasthenia gravis (neuromuscular junction).
2. Systemic Autoimmune Disorders: Affect multiple organs and systems.
   • Examples: Systemic lupus erythematosus (SLE), Rheumatoid arthritis, Scleroderma.

4. Pathophysiological Mechanisms of Autoimmunity

Autoimmune diseases arise through a combination of genetic susceptibility, immune dysregulation, and environmental triggers.

4.1. Loss of Self-Tolerance

The central event in autoimmunity is the failure of self-tolerance—the immune system’s inability to distinguish between self and non-self antigens.
This can occur due to:

• Defective elimination of autoreactive lymphocytes in the thymus or bone marrow.
• Defective regulation by Treg cells.
• Molecular mimicry, where foreign antigens resemble self-antigens, leading to cross-reactivity.

4.2. Genetic Factors

Certain genetic variations increase susceptibility:

• HLA (Human Leukocyte Antigen) genes play a central role.
  • Example: HLA-DR3 and HLA-DR4 are strongly associated with Type 1 diabetes and rheumatoid arthritis.
• Mutations in genes regulating immune tolerance (e.g., CTLA-4, PTPN22, FOXP3) can lead to T-cell overactivation.

These genetic predispositions alone are not sufficient; environmental factors usually trigger disease onset.

4.3. Environmental and Epigenetic Triggers

Environmental factors can initiate or exacerbate autoimmune responses in genetically predisposed individuals:

• Infections (e.g., Epstein-Barr virus, Coxsackievirus) via molecular mimicry.
• Drugs and toxins (e.g., hydralazine, procainamide in lupus-like syndrome).
• Ultraviolet radiation (induces apoptosis and exposes hidden nuclear antigens).
• Dietary factors (e.g., gluten in celiac disease).
• Stress and hormonal influences (autoimmune diseases are more prevalent in women, suggesting estrogen involvement).

Epigenetic mechanisms such as DNA methylation and histone modification also influence gene expression in autoimmunity.

4.4. Mechanisms of Tissue Damage

Autoimmune injury occurs through autoantibody production or T-cell–mediated mechanisms.

(a) Autoantibody-Mediated Damage

• B cells produce antibodies that target self-antigens.
• These antibodies can:
  • Form immune complexes → deposit in tissues → inflammation and complement activation (Type III hypersensitivity).
  • Bind directly to cell-surface receptors → alter function (Type II hypersensitivity).

Examples:

• Myasthenia gravis – antibodies block acetylcholine receptors.
• Graves’ disease – antibodies stimulate TSH receptors → hyperthyroidism.
• Systemic lupus erythematosus – immune complex deposition in kidneys, joints, and skin.

(b) T-Cell–Mediated Damage

• Cytotoxic T lymphocytes (CD8⁺) directly destroy self-cells.
• Helper T cells (CD4⁺) release cytokines → macrophage activation and inflammation (Type IV hypersensitivity).

Examples:

• Type 1 diabetes – T-cell destruction of pancreatic β-cells.
• Multiple sclerosis – T-cell attack on myelin sheaths in the CNS.

5. Pathophysiology of Selected Autoimmune Disorders

5.1. Rheumatoid Arthritis (RA)

Nature: Systemic inflammatory autoimmune disease primarily affecting synovial joints.

Pathophysiology:

1. Genetic predisposition (HLA-DR4) → immune dysregulation.
2. Activation of CD4⁺ T cells → cytokine release (TNF-α, IL-1, IL-6).
3. B cells produce rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA).
4. Chronic inflammation of synovial membrane → formation of pannus (granulation tissue).
5. Pannus invades cartilage and bone → joint destruction and deformity.

Systemic effects: Fatigue, anemia, vasculitis, cardiovascular involvement.

5.2. Systemic Lupus Erythematosus (SLE)

Nature: Multisystem autoimmune disease involving production of autoantibodies against nuclear components.

Pathophysiology:

1. Genetic and environmental triggers cause apoptosis and defective clearance of nuclear debris.
2. B cells produce autoantibodies (e.g., anti-dsDNA, anti-Smith).
3. Formation of immune complexes → deposition in tissues (kidneys, skin, joints).
4. Complement activation → inflammation and tissue injury.

Clinical effects: Butterfly rash, nephritis, arthritis, photosensitivity, and hematologic abnormalities.

5.3. Type 1 Diabetes Mellitus

Nature: Organ-specific autoimmune disease targeting pancreatic β-cells.

Pathophysiology:

1. Genetic predisposition (HLA-DR3, HLA-DR4) + viral trigger.
2. Autoreactive CD8⁺ T cells infiltrate pancreas → destroy insulin-producing β-cells.
3. Decreased insulin secretion → hyperglycemia.
4. Chronic metabolic effects: ketoacidosis, vascular damage, neuropathy.

5.4. Multiple Sclerosis (MS)

Nature: Chronic demyelinating disorder of the central nervous system.

Pathophysiology:

1. Autoreactive T cells cross the blood–brain barrier.
2. Attack myelin-producing oligodendrocytes → demyelination.
3. Impaired nerve conduction → muscle weakness, visual loss, and cognitive changes.
4. Repeated inflammatory episodes → neuronal death and scarring (sclerosis).

5.5. Hashimoto’s Thyroiditis

Nature: Autoimmune destruction of the thyroid gland.

Pathophysiology:

• T cells infiltrate thyroid → apoptosis of follicular cells.
• B cells produce anti-thyroglobulin and anti-thyroid peroxidase (TPO) antibodies.
• Leads to fibrosis and hypothyroidism (fatigue, weight gain, cold intolerance).

6. Immunopathological Mechanisms Summary

Mechanism	Example	Effect
Antibody-mediated cytotoxicity	Myasthenia gravis	Receptor blockade
Immune complex deposition	SLE	Inflammation, nephritis
T-cell cytotoxicity	Type 1 diabetes	Cell destruction
Chronic cytokine activation	Rheumatoid arthritis	Synovial inflammation
Molecular mimicry	Guillain-Barré syndrome	Autoimmune neuropathy

7. Systemic Effects of Autoimmune Pathology

• Chronic Inflammation: Persistent immune activation leads to oxidative stress and tissue degeneration.
• Organ Dysfunction: Depending on target tissue—e.g., thyroid failure, kidney damage, or joint deformity.
• Fatigue and Muscle Weakness: Due to cytokine-induced metabolic changes.
• Secondary Infections: From immunosuppressive therapy.
• Psychological Impact: Chronic pain and disability affect mental health.

8. Integrative and Yoga Therapy Perspective

From an integrative medicine and yoga therapy lens, autoimmune disorders are not only immunological but also psychoneuroimmunological conditions—where stress, emotions, and mind-body imbalance play significant roles.

Mechanisms Linking Stress and Autoimmunity

• Chronic stress increases cortisol and catecholamine levels, disrupting immune regulation.
• Alters balance between Th1 and Th2 immune responses.
• Suppresses Treg cell function → promotes autoimmunity.

Yoga Therapy Interventions

• Asanas: Gentle movements improve circulation and reduce inflammation.
• Pranayama: Breath regulation (e.g., Nadi Shodhana, Bhramari) calms autonomic imbalance.
• Meditation & Mindfulness: Reduces stress hormones, improves immune homeostasis.
• Dietary awareness (Ahara): Anti-inflammatory diet reduces oxidative load.
• Lifestyle (Dinacharya): Regularity, adequate rest, and emotional balance enhance resilience.

Evidence-based studies show that mind–body practices can downregulate inflammatory gene expression and support immune modulation—complementing biomedical therapy.

9. Summary

Autoimmune disorders represent a complex interplay of genetic predisposition, immune dysregulation, and environmental triggers. The central pathological process involves loss of self-tolerance, leading to chronic inflammation, tissue destruction, and organ dysfunction.

Although incurable in most cases, advances in immunotherapy, biologics, and integrative approaches (including yoga and mindfulness) offer hope for better symptom management and improved quality of life. Understanding the pathophysiology provides a foundation for both clinical treatment and holistic prevention of autoimmune disease.

Summary Table: Major Autoimmune Disorders and Key Pathophysiological Features

Disease	Target Tissue	Mechanism of Injury	Outcome
Type 1 Diabetes	Pancreatic β-cells	T-cell cytotoxicity	Insulin deficiency
Rheumatoid Arthritis	Synovial joints	Autoantibodies & cytokines	Joint destruction
SLE	Multiple organs	Immune complex deposition	Systemic inflammation
Hashimoto’s Thyroiditis	Thyroid gland	Autoantibody-mediated apoptosis	Hypothyroidism
Myasthenia Gravis	Neuromuscular junction	Receptor blockade	Muscle weakness
Multiple Sclerosis	CNS myelin	T-cell & macrophage attack	Demyelination